Logo image of SBS

CIA SANEAMENTO BASICO DE-ADR (SBS) Stock Fundamental Analysis

NYSE:SBS - New York Stock Exchange, Inc. - US20441A1025 - ADR - Currency: USD

20.1  -0.02 (-0.1%)

After market: 19.95 -0.15 (-0.75%)

Fundamental Rating

6

SBS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 14 industry peers in the Water Utilities industry. While SBS has a great profitability rating, there are some minor concerns on its financial health. SBS has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

In the past year SBS was profitable.
In the past year SBS had a positive cash flow from operations.
SBS had positive earnings in each of the past 5 years.
SBS had a positive operating cash flow in each of the past 5 years.
SBS Yearly Net Income VS EBIT VS OCF VS FCFSBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B 15B

1.2 Ratios

The Return On Assets of SBS (11.95%) is better than 100.00% of its industry peers.
With an excellent Return On Equity value of 26.66%, SBS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
The Return On Invested Capital of SBS (16.40%) is better than 100.00% of its industry peers.
SBS had an Average Return On Invested Capital over the past 3 years of 10.46%. This is significantly above the industry average of 5.08%.
The 3 year average ROIC (10.46%) for SBS is below the current ROIC(16.40%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.95%
ROE 26.66%
ROIC 16.4%
ROA(3y)7.67%
ROA(5y)5.86%
ROE(3y)16.39%
ROE(5y)12.54%
ROIC(3y)10.46%
ROIC(5y)8.95%
SBS Yearly ROA, ROE, ROICSBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

The Profit Margin of SBS (26.93%) is better than 85.71% of its industry peers.
SBS's Profit Margin has improved in the last couple of years.
SBS has a Operating Margin of 43.81%. This is amongst the best in the industry. SBS outperforms 100.00% of its industry peers.
SBS's Operating Margin has improved in the last couple of years.
SBS has a Gross Margin (53.66%) which is comparable to the rest of the industry.
SBS's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 43.81%
PM (TTM) 26.93%
GM 53.66%
OM growth 3Y26.98%
OM growth 5Y6.17%
PM growth 3Y30.85%
PM growth 5Y7.19%
GM growth 3Y16.63%
GM growth 5Y4.49%
SBS Yearly Profit, Operating, Gross MarginsSBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40 50

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), SBS is creating some value.
Compared to 1 year ago, SBS has about the same amount of shares outstanding.
The number of shares outstanding for SBS remains at a similar level compared to 5 years ago.
SBS has a better debt/assets ratio than last year.
SBS Yearly Shares OutstandingSBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
SBS Yearly Total Debt VS Total AssetsSBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.2 Solvency

An Altman-Z score of 2.39 indicates that SBS is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of SBS (2.39) is better than 85.71% of its industry peers.
SBS has a Debt/Equity ratio of 0.65. This is a neutral value indicating SBS is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.65, SBS belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACC1.25
WACC13.17%
SBS Yearly LT Debt VS Equity VS FCFSBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

SBS has a Current Ratio of 1.09. This is a normal value and indicates that SBS is financially healthy and should not expect problems in meeting its short term obligations.
SBS has a better Current ratio (1.09) than 64.29% of its industry peers.
A Quick Ratio of 1.08 indicates that SBS should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.08, SBS is doing good in the industry, outperforming 64.29% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.08
SBS Yearly Current Assets VS Current LiabilitesSBS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

5

3. Growth

3.1 Past

SBS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 184.24%, which is quite impressive.
The Earnings Per Share has been growing by 23.08% on average over the past years. This is a very strong growth
The Revenue has grown by 43.80% in the past year. This is a very strong growth!
The Revenue has been growing by 14.98% on average over the past years. This is quite good.
EPS 1Y (TTM)184.24%
EPS 3Y60.79%
EPS 5Y23.08%
EPS Q2Q%80.83%
Revenue 1Y (TTM)43.8%
Revenue growth 3Y22.86%
Revenue growth 5Y14.98%
Sales Q2Q%28.61%

3.2 Future

SBS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.41% yearly.
SBS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.97% yearly.
EPS Next Y-49.12%
EPS Next 2Y-13%
EPS Next 3Y-5.41%
EPS Next 5YN/A
Revenue Next Year-7.3%
Revenue Next 2Y2.41%
Revenue Next 3Y2.25%
Revenue Next 5Y3.97%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SBS Yearly Revenue VS EstimatesSBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B 40B
SBS Yearly EPS VS EstimatesSBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 5 10

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 7.47, the valuation of SBS can be described as very cheap.
SBS's Price/Earnings ratio is rather cheap when compared to the industry. SBS is cheaper than 100.00% of the companies in the same industry.
SBS is valuated cheaply when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 10.55 indicates a reasonable valuation of SBS.
Based on the Price/Forward Earnings ratio, SBS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.76, SBS is valued rather cheaply.
Industry RankSector Rank
PE 7.47
Fwd PE 10.55
SBS Price Earnings VS Forward Price EarningsSBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SBS is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.78
SBS Per share dataSBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The excellent profitability rating of SBS may justify a higher PE ratio.
A cheap valuation may be justified as SBS's earnings are expected to decrease with -5.41% in the coming years.
PEG (NY)N/A
PEG (5Y)0.32
EPS Next 2Y-13%
EPS Next 3Y-5.41%

3

5. Dividend

5.1 Amount

SBS has a yearly dividend return of 0.59%, which is pretty low.
Compared to an average industry Dividend Yield of 3.32, SBS is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.35, SBS's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.59%

5.2 History

The dividend of SBS has a limited annual growth rate of 4.65%.
SBS has paid a dividend for at least 10 years, which is a reliable track record.
SBS has decreased its dividend recently.
Dividend Growth(5Y)4.65%
Div Incr Years1
Div Non Decr Years1
SBS Yearly Dividends per shareSBS Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

9.07% of the earnings are spent on dividend by SBS. This is a low number and sustainable payout ratio.
DP9.07%
EPS Next 2Y-13%
EPS Next 3Y-5.41%
SBS Yearly Income VS Free CF VS DividendSBS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B
SBS Dividend Payout.SBS Dividend Payout, showing the Payout Ratio.SBS Dividend Payout.PayoutRetained Earnings

CIA SANEAMENTO BASICO DE-ADR

NYSE:SBS (7/11/2025, 8:04:00 PM)

After market: 19.95 -0.15 (-0.75%)

20.1

-0.02 (-0.1%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryWater Utilities
Earnings (Last)05-12 2025-05-12/amc
Earnings (Next)08-11 2025-08-11/amc
Inst Owners40.17%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap13.74B
Analysts83
Price Target23.95 (19.15%)
Short Float %0.76%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 0.59%
Yearly Dividend0.24
Dividend Growth(5Y)4.65%
DP9.07%
Div Incr Years1
Div Non Decr Years1
Ex-Date05-02 2025-05-02 (0.471646)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.81%
Min EPS beat(2)-19.39%
Max EPS beat(2)5.76%
EPS beat(4)3
Avg EPS beat(4)103.22%
Min EPS beat(4)-19.39%
Max EPS beat(4)412.07%
EPS beat(8)4
Avg EPS beat(8)48.05%
EPS beat(12)6
Avg EPS beat(12)36.67%
EPS beat(16)7
Avg EPS beat(16)26.13%
Revenue beat(2)2
Avg Revenue beat(2)21.58%
Min Revenue beat(2)20.14%
Max Revenue beat(2)23.03%
Revenue beat(4)4
Avg Revenue beat(4)49.17%
Min Revenue beat(4)17.4%
Max Revenue beat(4)136.1%
Revenue beat(8)8
Avg Revenue beat(8)33.82%
Revenue beat(12)12
Avg Revenue beat(12)28.69%
Revenue beat(16)16
Avg Revenue beat(16)25.78%
PT rev (1m)4.05%
PT rev (3m)9.37%
EPS NQ rev (1m)4.22%
EPS NQ rev (3m)2.4%
EPS NY rev (1m)0%
EPS NY rev (3m)7.57%
Revenue NQ rev (1m)-3.85%
Revenue NQ rev (3m)-9.36%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.36%
Valuation
Industry RankSector Rank
PE 7.47
Fwd PE 10.55
P/S 2.01
P/FCF N/A
P/OCF 10.76
P/B 1.99
P/tB N/A
EV/EBITDA 4.78
EPS(TTM)2.69
EY13.38%
EPS(NY)1.91
Fwd EY9.48%
FCF(TTM)-0.5
FCFYN/A
OCF(TTM)1.87
OCFY9.3%
SpS9.99
BVpS10.09
TBVpS-1.69
PEG (NY)N/A
PEG (5Y)0.32
Profitability
Industry RankSector Rank
ROA 11.95%
ROE 26.66%
ROCE 22.73%
ROIC 16.4%
ROICexc 18.45%
ROICexgc 59.11%
OM 43.81%
PM (TTM) 26.93%
GM 53.66%
FCFM N/A
ROA(3y)7.67%
ROA(5y)5.86%
ROE(3y)16.39%
ROE(5y)12.54%
ROIC(3y)10.46%
ROIC(5y)8.95%
ROICexc(3y)11.27%
ROICexc(5y)9.66%
ROICexgc(3y)60.48%
ROICexgc(5y)53.53%
ROCE(3y)14.49%
ROCE(5y)12.4%
ROICexcg growth 3Y19.27%
ROICexcg growth 5Y-4.83%
ROICexc growth 3Y38.93%
ROICexc growth 5Y9.98%
OM growth 3Y26.98%
OM growth 5Y6.17%
PM growth 3Y30.85%
PM growth 5Y7.19%
GM growth 3Y16.63%
GM growth 5Y4.49%
F-Score6
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF N/A
Debt/EBITDA 1.29
Cap/Depr 361.7%
Cap/Sales 23.66%
Interest Coverage 7.36
Cash Conversion 37.13%
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.08
Altman-Z 2.39
F-Score6
WACC13.17%
ROIC/WACC1.25
Cap/Depr(3y)198.74%
Cap/Depr(5y)185.31%
Cap/Sales(3y)18.28%
Cap/Sales(5y)18.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)184.24%
EPS 3Y60.79%
EPS 5Y23.08%
EPS Q2Q%80.83%
EPS Next Y-49.12%
EPS Next 2Y-13%
EPS Next 3Y-5.41%
EPS Next 5YN/A
Revenue 1Y (TTM)43.8%
Revenue growth 3Y22.86%
Revenue growth 5Y14.98%
Sales Q2Q%28.61%
Revenue Next Year-7.3%
Revenue Next 2Y2.41%
Revenue Next 3Y2.25%
Revenue Next 5Y3.97%
EBIT growth 1Y153.09%
EBIT growth 3Y56.01%
EBIT growth 5Y22.08%
EBIT Next Year-7.45%
EBIT Next 3Y11.68%
EBIT Next 5Y13.83%
FCF growth 1Y-1142.94%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y89.74%
OCF growth 3Y23.68%
OCF growth 5Y12.02%